Occlusion Therapy Research Articles

A MOF-based nanobomb for tumor microvascular occlusion and combined tumor starvation therapy and chemotherapy

As an important approach of tumor starvation therapy, vascular blockage has been widely studied and used in cancer therapy. Recently, thrombin, a common endogenous coagulation protease, has been adopted in cancer starvation therapy. However, intravenous injection of thrombin can cause severe toxicity to the body and single cancer starvation therapy always exhibits limited therapeutic effect. Here, we utilized a type of acid-responsive metal–organic framework (MOF) material (zeolitic imidazolate framework-8, ZIF-8) to encapsulate thrombin and doxorubicin (DOX) for realizing tumor microenvironment-triggerable tumor starvation-chemo combination therapy without the requirement of external stimuli. The as-designed material (termed TD@Z) displayed proper size, nanopopcorn morphology, and significant coagulation effect under pH 6.5 condition. In vitro cellular experiments revealed that the TD@Z “nanobomb” exhibited increased cell endocytosis and could achieve lysosomal escape, thus resulting in strong cell apoptosis. Moreover, superb tumor microvascular blockage and tumor inhibition effects were demonstrated via blood flow imaging and tumor vessel immunofluorescence staining experiments. Further, restricted blood flow could lead to local drug accumulation, thereby enhancing the chemotherapeutic effect of TD@Z. This work may promote the practical use of thrombin in cancer nanotherapy and inspire the design of other enzyme-incorporated MOF-based nanodrugs.

Computer-Assisted Visual Training in Children and Adolescents With Developmental Visual Disorders—a Systematic Review.

In this systematic review, we address the question whether children and adolescents with developmental visual disorders benefit from computer-assisted visual training. Systematic literature searches were carried out in three bibliographic databases (initial search in October 2021) and trial registries. Included were randomized controlled trials that evaluated the efficacy of computer-assisted visual training in children and adolescents with developmental visual disorders in comparison to no training, sham training, or conservative treatment. The inclusion criteria were met by 17 trials (with a total of 1323 children and adolescents) focusing on binocular or monocular computer-assisted visual training for the treatment of amblyopia. In these trials, visual training was carried out for 2 to 24 weeks, either as "stand alone" therapy or in addition to occlusion therapy. Six trials showed a statistically significant difference in favor of the visual training for the outcome "best corrected visual acuity of the amblyopic eye." However, this difference was small and mostly below the threshold of clinical relevance of -0.05 logMAR (equivalent to an improvement of 0.5 lines on the eye chart, or 2.5 letters per line). Only few data were available for the outcomes "binocular vision" and "adverse events"; the differences between the groups were similarly small. The currently available data do not permit any firm conclusions regarding the efficacy of visual training in children and adolescents with amblyopia. Moreover, treatment adherence was often insufficient and the treatment durations in the trials was relatively short. No results from randomized trials have yet been published with respect to other developmental visual disorders (refractive errors, strabismus).

Short-term efficacy of stenting as a rescue therapy for acute atherosclerotic occlusion in anterior cerebral circulation.

The study aimed to explore the efficacy and safety of the Neuroform EZ stent in treating acute anterior circulation large artery occlusion. The clinical data of 42 consecutive patients with acute anterior circulation large atherosclerotic occlusion who were treated with the Neuroform EZ stent from January 2018 to August 2019 in our stroke care center, including baseline characteristics, images, therapeutic condition, and follow-up data were retrospectively analyzed. There were 42 mechanical thrombectomy (MT) failure cases of intracranial atherosclerotic stenosis with rescue Neuroform EZ stent implantation, of which 78.6% (33/42) had a good prognosis and 88.1% (37/42) showed no re-stenosis at follow-up. The average time from puncture to recanalization is 79.50 ± 14.19 min. The successful rate of intraoperative stent release is 97.6%, while there is one case of stent displacement, three cases of thrombus escape, and six cases of hemorrhage. Rescue therapy of the Neuroform EZ stent for acute anterior circulation large atherosclerotic occlusion can archive good short-term imaging and clinical results, while long-term follow-up is still needed to verify.

Abstract 107: Endovascular Therapy for Tandem Vertebral and Basilar Artery Occlusion in a Patient with Low NIHSS

Introduction Basilar artery occlusion (BAO) is a devastating minority stroke subtype with variable clinical presentations and high mortality.1,2 The National Institute of Health Stroke Scale (NIHSS) cutoff for poor outcomes is lower in BAO compared to anterior circulation large vessel occlusions (LVO) due to the scale’s weighted scoring towards cortical signs.3,4 To bridge this gap, Alemseged et.al created the underutilized posterior circulation (PC) NIHSS as an improved stroke assessment tool in PC LVO to better identify endovascular therapy (EVT) candidates. 5 Current randomized trials point to mixed evidence regarding EVT for BAO; although recent studies such as Endovascular Treatment for Acute Basilar Artery Occlusion (ATTENTION)6 and Basilar Artery Occlusion Chinese Endovascular Trial (BAOCHE)7 suggest positive results of EVT within 24hrs. Smaller retrospective subgroup analyses demonstrated EVT for BAO with low NIHSS has good clinical outcome of modified Rankin Scale (mRS) 0‐2 at 3 months in 60‐70% of patients4,8. We present a case of tandem vertebrobasilar artery occlusion in a patient with subacute symptoms and low NIHSS treated with mechanical thrombectomy. Methods '‐ Results 41‐year‐old male with past medical history of hypertension, insulin dependent diabetes and active smoking presented with worsening vertigo, nausea and vomiting for 3 weeks with progression to right sided headache and syncope. EMS noted right facial weakness prompting transport to nearest primary stroke center where CT head non‐contrast showed right cerebellar infarct and CT angiogram (CTA) head and neck showed right vertebral artery occlusion with basilar extension. Intravenous thrombolytic (IVT) was deferred due to unclear last known well. He was treated with aspirin 324mg and transferred to our tertiary stroke center. Arrival NIHSS was 1 for right upper extremity ataxia. Premorbid mRS was 0. Repeat CTA redemonstrated right vertebrobasilar artery tandem occlusion. CT perfusion was without mismatch. Patient underwent emergent mechanical thrombectomy with ADAPT to TICI3 revascularization with future plan for possible angioplasty and stenting of R vertebral stenosis. Subsequently admitted to neurocritical care unit and treated with dual antiplatelet therapy. Initially maintained on aspirin and Cangrelor infusion, then transitioned to aspirin and Plavix without hemorrhagic conversion. Diffusion weighted MRI brain showed right cerebellar and right pontine infarcts. Hospital course was complicated by severe intractable hiccups due to area postrema syndrome; ultimately resolved with baclofen and gabapentin after extensive unsuccessful medication trails. NIHSS remained 1 for ataxia throughout admission, although exam also revealed mild unsteady gait requiring home physical therapy and a walker on discharge. Post‐stroke mRS was 1 on discharge; 3‐month mRS is pending. Conclusion Evidence regarding EVT for low NIHSS BAO remains varied with some studies showing superior benefit with IVT alone9 while others suggest improved outcomes with EVT in mild to moderate deficits.4,8 One prospective study particularly revealed better outcomes in EVT for BAO due to tandem occlusions similar to this case.10 Given the potential devastating sequalae of BAO and limited overall treatment options, EVT should remain a strong contender for treatment of PC LVO, especially in patients with milder neurologic deficits or tandem occlusions. Additionally, heightened use of PC‐NIHSS may better prognosticate candidates for EVT.

Abstract 203: Predicting Outcomes After Mechanical Thrombectomy: Early vs Delayed Neurological Improvement in the SELECT Database

Introduction Understanding of patient benefit and improvement following mechanical thrombectomy in ischemic stroke has made tremendous strides in recent years, however clinicians still struggle to accurately predict patient outcomes and long‐term neurological functioning following large vessel occlusion and endovascular therapy. These limitations are further complicated by a highly variable time course of improvement following intervention that spans from minutes to months. Prior literature has shown that successful reperfusion is associated with better outcomes even in the absence of early improvement. Delayed neurological improvement may be the result of microvasculature effects and inflammatory changes, and is likely multifactorial. Improved understanding of predictors of early versus delayed neurological improvement in this population may help inform goals of care, aid in clinical decision making, and manage patient and family expectations. Methods Patient data from the SELECT database was retrospectively analyzed. The SELECT study was a prospective, non‐randomized, multicenter cohort study that enrolled patients with acute ischemic stroke due to anterior circulation large vessel occlusion at nine US centers between 1/2016 and 2/2018, with patients falling into either the mechanical thrombectomy or medical management arm. Only patients in the mechanical thrombectomy arm (n=149) were included in this analysis. Possible predictors of early vs late neurological improvement were segregated into pre‐procedure (age, NIHSS at baseline, IV thrombolytic therapy, transfer status, occlusion location, ischemic core, ischemic penumbra, hypoperfusion intensity ratio, successful reperfusion, type of anesthesia, time from last known well to puncture, time from puncture to reperfusion) and post‐procedure (NIHSS at 24‐hour follow‐up, ASPECTS on follow‐up imaging, ASPECTS point loss from baseline, infarct volume on follow‐up imaging, infarct growth from baseline ischemic core, neurological worsening, midline shift, hemorrhagic transformation and type). Backwards stepwise regression was used to identify significant predictors of early and delayed improvement. Results Pre‐procedure predictors of early neurological improvement (defined as mRS 0‐2 at discharge) were age (p=0.001), NIHSS score (p=0.002), ischemic core volume (p=0.001), transfer status (p=0.019), and successful reperfusion (defined as mTICI 2b or better, p=0.001). Post‐procedure predictor of early neurological improvement was NIHSS score at 24 hours (p<0.001). Pre‐procedure predictor of delayed neurological improvement (defined as mRS 0‐2 at 90 days among those who did not achieve early neurological improvement) was ischemic core volume (p=0.003). Post‐procedure predictors of delayed neurological improvement were final infarct volume (p=0.012), change in ASPECTS on follow‐up imaging (p=0.001), and growth in infarct size (p=0.030). Pre‐procedure predictors of early excellent outcome (defined as mRS 0‐1 at discharge) were age (p=0.001), NIHSS score (p<0.001), successful reperfusion (p=0.001), ischemic core volume (p=0.004), and infarct growth rate (p=0.034). Pre‐procedure predictor of delayed excellent outcome (defined as mRS 0‐1 at 90 days among those who did not achieve early excellent outcome) was NIHSS score (p=0.002). Additionally, midline shift of 5mm or more at 24 hours was associated with poor outcome at 90 days. Conclusion Several demographic, imaging, and clinical factors were found to correlate with either early or delayed neurological improvement. Further investigation may help delineate how these predictors can be utilized to inform clinical decisions and discussions regarding stroke patients receiving mechanical thrombectomy.

Ischemic stroke patients with low DWI ASPECTS scores require puncture to recanalization within 30 min for large vessel occlusion

The clinical benefits of faster recanalization in acute large vessel occlusion are well recognized, but the optimal procedure time remains uncertain. The aim of this study was to identify patient characteristics that necessitate puncture-to-recanalization (P-R) time within 30min to achieve favorable outcome. We evaluated the patients from a prospective, multicenter, observational registry of acute ischemic stroke patients. The study included patients who underwent endovascular therapy for ICA or MCA M1 occlusion and achieved successful recanalization. Patients were categorized into subgroups based on pre-treatment characteristics and the frequency of favorable outcomes was compared between P-R time<30min and≥30min. Interaction terms were incorporated into the models to assess the correlation between each patient characteristic and P-R time. A total of 1053 patients were included in the study. Univariate analysis within each subgroup revealed a significant association between P-R<30min and favorable outcomes in patients with DWI ASPECTS ≤6, age>85 and NIHSS ≥16. In the multivariable analysis, NIHSS, age, time from symptom recognition to puncture, and DWI ASPECTS were significant independent predictors of favorable outcomes. Notably, only DWI ASPECTS exhibited interaction terms with P-R<30min. The multivariable analysis indicated that P-R<30min was an independent predictor for favorable outcome in DWI ASPECTS ≤6 group, whereas not in DWI ≥7. P-R time<30min is predictive of favorable outcomes; however, the effect depends on DWI ASPECTS. Target P-R time<30min is appropriate for patients with DWI ASPECTS ≤6.

Personalised versus standardised dosing of occlusion therapy for amblyopia: A randomised controlled trial

ObjectivesTo compare a novel, model-based personalised dosing strategy (PDS) with a standardised (best practice) occlusion dosing strategy (SDS) for the treatment of childhood amblyopia. We have utilised archived clinical trial data sets to develop a statistical model that aims to optimise the prescription of occlusion therapy. This approach, whose effectiveness has not previously been evaluated, incorporates within its underlying model: patient age, severity and type of amblyopia. MethodsRandomised, parallel group design with PDS and SDS arms each having within or pre-trial optical treatment. Actual worn occlusion for both PDS and SDS groups was objectively recorded using occlusion dose monitors (ODMs). ResultsOf the 94 initially enrolled participants, 50 were male, 44 female, mean [IQR] age 5.53 [4.79–6.02] years. The improvement in logMAR acuity in the 68 participants remaining in the trial subsequent to optical treatment and not having withdrawn did not differ (p = 0.641) between the PDS and SDS groups: median [IQR] improvement 0.250 [0.13−0.39] in the PDS group, 0.225 [0.14−0.32] in the SDS group. A subset (n = 28) of participants were objectively observed to have occluded for every day prescribed. In these, we found that, after allowing for slightly higher prescribed doses of occlusion in the SDS group, adherence in the PDS group to be ∼20% greater than in the SDS group. ConclusionWhilst the PDS and SDS groups demonstrated equivalent visual performance and temporal outcomes, there is evidence that the PDS results in improved adherence with therapy likely to have arisen due to increased patient engagement with this novel regimen.

Visual parameter status as a predictive factor for the outcomes of occlusion therapy in anisometropic amblyopia.

The purpose is to compare visual parameters between normal and amblyopic eyes in anisometropic amblyopia and to find predictive factors for occlusion therapy. Sixty patients with anisometropic amblyopia between the ages of 5 and 25 years were enrolled in the prospective, longitudinal, and interventional study. Patients were selected based on no improvement with spectacle correction alone after 1 month of follow-up. Baseline parameters such as LogMAR visual acuity, LEA contrast sensitivity, TNO stereopsis test, online Farnsworth D-15 test for color vision, accommodation with RAF ruler, +2.00/-2.00 flipper test, and dynamic retinoscopy were recorded. All patients were treated with occlusion therapy depending on their grades of amblyopia. After 6 months of follow-up, improvement in visual acuity was recorded with a LogMAR chart and correlated with initial visual parameters. Paired "t" test, Chi-square test, independent "t" test, analysis of variance test were used as statistical analysis. Visual functions such as contrast sensitivity, accommodative facility, near point of accommodation, and accommodative amplitude showed a statistically significant difference between normal and amblyopic eyes of anisometropic amblyopia patients, whereas color vision did not differ significantly between normal and amblyopic eyes. Sixty-seven percentage of patients had poor stereopsis. Eighty percentage of patients who were younger had improvement in final best-corrected visual acuity and these patients had better stereopsis, contrast sensitivity, and mild-to-moderate amblyopia on initial testing. The age of the patient, degree of anisometropia, spherical equivalent in amblyopic eyes, stereopsis, contrast sensitivity values at initial presentation, and compliance to occlusion therapy were found to be positive predictive factors of occlusion therapy.

Is there value in measuring near visual acuity during occlusion therapy for amblyopia?

ABSTRACT Introduction: The purpose of this study was to investigate near and distance visual acuity (VA) prior to, during and on completion of occlusion therapy for amblyopia. Method: Fifty-four patients aged 4–7 years (mean 4.9; ±0.44) with untreated strabismic, anisometropic or mixed amblyopia were recruited to the study following refractive adaptation where applicable. All patients underwent conventional occlusion (patching). Uniocular near and distance VA was tested using age and ability appropriate Crowded LogMAR VA tests prior to, during and upon conclusion of occlusion therapy. Results: In amblyopic eyes, there was no significant difference between near and distance VA prior to occlusion therapy with LogMAR Crowded (p = .66; mean distance VA at 3 m = 0.6 LogMAR; mean near VA at 40 cm = 0.58 LogMAR), or with LogMAR Crowded Kay Picture test (p = .78, mean distance VA at 3 m = 0.44 LogMAR; mean near VA at 33 cm = 0.46 LogMAR;). No significant difference was found between near and distance VA at any visit during occlusion therapy, or on completion of occlusion therapy with LogMAR Crowded (p = .86, mean final distance VA at 3 m = 0.266 LogMAR; mean final near VA at 40 cm = 0.25 LogMAR) or LogMAR Crowded Kay Pictures (p = .74, mean final distance VA at 3 m = 0.16 LogMAR; mean final near VA at 33 cm = 0.16 LogMAR). There was no significant difference in the VA of the fellow (non-amblyopic) eyes prior to and on completion of occlusion therapy with LogMAR Crowded at distance (3 m) or near (40 cm) (p = .05, p = .40 respectively); or with LogMAR Crowded Kay Pictures at distance (3 m) or near (33 cm) (p = .89, p = .35 respectively). Discussion: Improvement in VA of amblyopic eyes did not significantly differ between near and distance testing proximites at any point during the course of occlusion therapy for amblyopia in our study. These findings may aid clinicians with appropriate test selection and help with clinical time pressures. Where patient concentration does not allow for uniocular distance vision, uniocular near vision may be used to diagnose amblyopia, and vice versa. This could prevent delay in the treatment of amblyopia.

TCT-417 10-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE Trial

TCT-417 10-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE Trial

Mid-Term Feasibility of Percutaneous Left Atrial Appendage Occlusion in Elderly Patients with Non-Valvular Atrial Fibrillation.

Percutaneous left atrial appendage occlusion (LAAO) therapy using the WATCHMAN system has been introduced to prevent thrombosis and minimize the use of anticoagulants in patients with non-valvular atrial fibrillation. Given the high risk of bleeding and stroke in elderly patients, these patients would be good candidates for this therapy. However, the efficacy and feasibility of LAAO therapy in elderly patients remains uncertain. Consecutive patients who underwent LAAO therapy using the WATCHMAN system in a large academic center between June 2020 and March 2023 were included. The safety and efficacy of LAAO therapy during the 1-year observation period in patients aged ≥85 years old were compared with those in the younger cohort. A total of 188 patients (78.4 ± 6.9 years old, 133 male patients) were included. 34 patients were ≥85 years old, 96 were between 75 and 84 years old, and 58 were <75 years old. The elderly group had a higher CHA2DS2-VASc score and were at greater risk of falling-related bleeding compared with the younger cohort. The device implantations were successful in all patients except for one. During the 1-year observation period, one patient had a peri-device leak >5 mm and there were 6 device-related cases of thrombosis, whose incidence was not significantly different between the groups (p = 0.98). The cumulative incidences of bleeding and thrombotic events in the elderly group were as low as in the younger cohort (p > 0.05 for both). Most anticoagulants were terminated regardless of age. The mid-term feasibility and efficacy of percutaneous LAAO therapy using the WATCHMAN system in elderly patients aged ≥85 years were as acceptable as in the younger cohort.

A novel therapy in microvascular obstruction in ST-elevation myocardial infarction: pressure-controlled intermittent coronary sinus occlusion therapy.

Percutaneous coronary intervention has transformed the management of ST-elevation myocardial infarction (STEMI) due to a reduction in early mortality and need for repeat revascularization. However, the conventional revascularization strategy, combined with state-of-the-art anti-thrombotic and antiplatelet therapies, can still be associated with poor clinical outcome in some patients, because of reperfusion injury and microvascular obstruction contributing to the infarct size. To address this important therapeutic need, a broad-range of device-based treatments have been introduced. This is an overview of the pressure-controlled intermittent coronary sinus occlusion (PiCSO) device (Miracor Medical SA) which has been proposed for STEMI patients. PiCSO therapy could lead to an improved perfusion, decrease microvascular dysfunction, and thus potentially reduce infarct size.

Levodopa/Carbidopa to Augment the Treatment of Amblyopia: A Report by the American Academy of Ophthalmology

To review the published literature on the use of levodopa/carbidopa to augment the treatment of amblyopia. Literature searches for English language studies were last conducted in October 2022 in the PubMed database with no date restrictions. The combined searches yielded 55 articles, of which 23 were reviewed in full text. Twelve of these were considered appropriate for inclusion in this assessment and were assigned a level of evidence rating by the panel methodologist. Nine studies were rated level I, and 3 studies were rated level II; there were no level III studies. The duration of treatment was limited to 3 to 16 weeks because of concern about long-term adverse effects such as tardive dyskinesia. This complication was not reported in any of the study participants. The dose of levodopa ranged from 1.5 to 8.3 mg/kg/day, generally divided into 3 daily doses. The carbidopa dose was approximately 25% of the levodopa dose in all treatments. Evidence from these studies indicates that augmenting traditional patch occlusion therapy with the oral administration of levodopa/carbidopa can improve the vision of amblyopic children, but the effect was small (0.17-0.3 logarithm of the minimum angle of resolution [logMAR] units) and only statistically significant when compared with patching alone in 2 of the 12 studies cited. Regression of vision was reported in the majority of studies (9 of 12 reported; range, 0-0.17 logMAR unit regression) after discontinuation of therapy. Short-term side effects of the medications were not consistently reported but were most frequently mild and included headache and nausea. The best available evidence is currently insufficient to show that augmenting amblyopia therapy using up to 16 weeks of levodopa/carbidopa will result in meaningful improvement in visual acuity. Given the potential for significant side effects such as tardive dyskinesia with long-term therapy, levodopa/carbidopa does not appear to be a viable option for amblyopia therapy FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Attitude of Italian dental practitioners toward bruxism assessment and management: A survey-based study.

Bruxism is a spectrum of masticatory muscles activities. According to the recent evidence and international consensus, there is no indication to treat bruxism unless clinical consequences are present. The aim of the present study was to investigate the approach of Italian dentists to bruxism in their clinical practice. An anonymous online survey was developed, composed by 26 items grouped into five sections: (1) Characteristics of the respondent (Q1-Q6); (2) Bruxism frequencies (Q7-Q11); (3) Bruxism assessment (Q12-Q15); (4) Bruxism management (Q16-Q20); (5) Occlusal splints therapy (Q21-Q26). A total of 384 practitioners, including specialists and non-specialists, participated in this survey. The majority of the respondents reported that 1-3 out of ten patients presented with bruxism. The diagnosis is mainly performed with non-instrumental methods, and facial pain and dental wear are the major clinical consequence associated with bruxism. Almost the entire sample of respondents report to offer occlusal splints to bruxism patients, and 41% refer to perform occlusal adjustments. Almost half of the respondents have never proposed any form of cognitive-behavioural therapy. The results of the current survey highlighted several inconsistencies in Italian dentists' approaches to bruxism, suggesting the need for better education of practitioners and for the development of a standardized protocol to assess and manage bruxism in dental practices.

Correlation between Visual Acuity, Contrast Sensitivity and Depth of Vision before and after Partial Time Occlusion Therapy in Strabismic and Anisometropic Amblyopes

Background Amblyopia is known as the visual developmental disorder that follows selective disruption of the visual input to one eye early in life. It is considered the second most common cause of decreased visual acuity in both children and adults affecting greatly both economic and social life. It affects most of the visual parameters, so great efforts are carried out in developing effective methods controlling different deficits in amblyopia, being a great concern for all the society. However, monocular occlusion therapy remains the easiest and most popular way despite that there are many doubts in its reliability in controlling visual abnormalities other than acuity. Purpose To compare the different performance of anisometropic and strabismic eyes with moderate amblyopia, using partial occlusion therapy regarding visual acuity, contrast sensitivity and depth of vision. Methods Forty-nine children between 7 and 12 years old suffering from moderate amblyopia were classified into two groups: 25 anisometropic amblyopes and 24 strabismic ones. Two hour occlusion regimen with near activity was conducted by patients, assured by parents monitoring. Evaluation of visual acuity, contrast sensitivity and stereoacuity was conducted at each visit throughout the treatment regimen which was continued for 6 months on monthly follow up basis. Results Children in both groups improved significantly in visual acuity. There was a considerable difference among the distribution of improvement within each group where 9% of strabismic amblyopes achieved full visual recovery as compared to 40% in the anisometropic group, and 62.5% had residual amblyopia as compared to 36% in the anisometropic one, in spite of no significant difference of average improvement between groups (&amp;lt;0.0001). Only 42% of the strabismic amblyopes improved in stereoacuity as compared to 88% of the anisometropic ones, however, the difference in mean improvement was not significant between the two groups. Conclusion Children with moderate anisometropic or strabismic amblyopia 7-12 years old, can get considerable benefits from part time occlusion therapy in different visual aspects. The anisometropic amblyopes have better contrast sensitivity improvement and more reliable expectations of recovery being largely dependent on the initial visual acuity.

Management of intracranial arterial stenosis during mechanical thrombectomy: Survey of neuro-interventionalists.

The optimal management of emergent large vessel occlusion due to underlying intracranial stenosis (intracranial stenosis related large vessel occlusion) remains unknown. The primary aim of this survey analysis was to measure variation in the clinical management of intracranial stenosis related large vessel occlusion during mechanical thrombectomy. A survey was designed using a web-based survey-building platform and distributed via the Society of NeuroInterventional Surgery (SNIS) and the Society of Vascular and Interventional Neurology (SVIN) websites for a response. Predictors of respondents' level of comfortability stenting were estimated using a binomial logistic regression model. We received 105 responses to the survey. Most respondents (54.3%) practiced at an academic Stroke Center. Nearly half of the respondents (49%) had been practicing for 5 or more years independently after fellowship. An average of 54 mechanical thrombectomies were performed by each respondent annually. There was variation in the definition of intracranial stenosis related large vessel occlusion, number of passes performed before pursuing rescue stenting, as well as intra and post-procedural antiplatelet management. Of respondents, 58% felt rescue stenting was very risky, and 55.7% agreed that there was equipoise regarding emergent angioplasty and/or stenting versus medical therapy for intracranial stenosis related large vessel occlusion. Respondents who encountered intracranial stenosis related large vessel occlusion more frequently thought that rescue stenting was less risky. There is notable variability in the diagnosis and management of intracranial stenosis related large vessel occlusion during mechanical thrombectomy. While most respondents felt rescue stenting was risky, the majority believed the benefit could outweigh the risk. The majority of respondents agreed that equipoise exists regarding the management of intracranial stenosis related large vessel occlusion, highlighting the need for clinical trials in this rare patient population.

Tapping the potential of rapid prototyping techniques in creating a paradigm shift in the fabrication of occlusal splints

PurposeThis study aims to cover the overall gamut of rapid prototyping processes and biomaterials used for the fabrication of occlusal splints in a comprehensive manner and elucidate the characteristics of the materials, which are essential in determining their clinical efficacy when exposed to oral surroundings.Design/methodology/approachA collective analysis of published articles covering the use of rapid prototyping technologies in the fabrication of occlusal splints, including manufacturing workflow description and essential properties (mechanical- and thermal-based) evaluation of biocompatible splinting materials, was performed.FindingsWithout advances in rapid prototyping processes and materials engineering, occlusal splints would tend to underperform clinically due to biomechanical limitations.Social implicationsThree-dimensional printing can improve the process capabilities for commercial customization of biomechanically efficient occlusal splints.Originality/valueRapid technological advancement in dentistry with the extensive utilization of rapid prototyping processes, intra-oral scanners and novel biomaterial seems to be the potential breakthrough in the fabrication of customized occlusal splints which have endorsed occlusal splint therapy (OST) as a cornerstone of orthodontic treatment.

Short-term effects of occlusion therapy and optical correction on microvasculature in monocular amblyopia: a retrospective case–control study

This retrospective longitudinal case–control study investigated the short-term effects of patch occlusion treatment compared with optical correction on the microvasculature in monocular amblyopia. We included patients with monocular amblyopia treated for 2–12 months; they were classified into two groups according to the treatment regimen: patch occlusion or optical correction. Children aged < 12 years who presented to our clinic for examination without amblyopia diagnosis were enrolled as the control group. Changes in retinal and choroid microvasculature according to treatment were examined, and the correlation between changes in microvasculature and improvement in best-corrected visual acuity (BCVA) was evaluated. There were 57, 35, and 41 patients in the patch occlusion, optical correction, and control groups, respectively (mean age, 6.4 ± 2.0 years). Both amblyopic groups showed changes in the foveal and parafoveal deep capillary plexus vessel density (DCPD), choroidal thickness, and choroidal vascularity index (CVI) following short-term treatment (mean, 4.5 months). In the patch occlusion group, BCVA improved as the foveal DCPD increased (P = 0.013) and the CVI decreased (P = 0.037). In the optical correction group, BCVA improved as the foveal and parafoveal DCPD increased (P = 0.009). Increased foveal DCPD following amblyopia treatment and decreased CVI by patch occlusion were associated with improved BCVA.

Contour integration deficits at high spatial frequencies in children treated for anisometropic amblyopia.

This study was conducted to reexamine the question of whether children treated for anisometropic amblyopia have contour integration deficits. To do so, we used psychophysical methods that require global contour processing while minimizing the influence of low-level deficits: visibility, shape perception, and positional uncertainty. Thirteen children with anisometropic amblyopia (age: 10.1 ± 1.8 years) and thirteen visually normal children (age: 10.8 ± 2.0 years) participated in this study. The stimuli were closed figures made up of Gabor patches either in noise or on a blank field. The contrast thresholds to detect a circular contour on a blank field, as well as the thresholds of aspect ratio and contour element number to discriminate a circular or elliptical contour in noise, were measured at Gabor spatial frequencies of 1.5, 3, and 6 cpd for amblyopic eyes (AEs), fellow eyes (FEs), and normal control eyes. Visual acuities and contrast sensitivity functions for AEs and FEs and the Randot stereoacuity were measured before testing. The AEs showed contrast deficits and degraded shape perception compared to the FEs at higher spatial frequencies (6 cpd). When the influence of abnormal contrast sensitivity and shape perception were minimized, the AEs showed contour integration deficits at spatial frequencies 3 and 6 cpd. These deficits were not related to basic losses in contrast sensitivity and acuity, stereoacuity, and visual crowding. Besides, no significant difference was found between the fellow eyes of the amblyopic children and the normal control eyes in the performance of contour integration. After eliminating or compensating for the low-level deficits, children treated for anisometropic amblyopia still show contour integration deficits, primarily at higher spatial frequencies, which might reflect the deficits in global processing caused by amblyopia. Contour integration deficits are likely independent of spatial vision deficits. Refractive correction and/or occlusion therapies may not be sufficient to fully restore contour integration deficits, which indicates the need for the development of clinical treatments to recover these deficits.

Association Between Recanalization Attempts and Functional Outcome After Thrombectomy for Large Ischemic Stroke.

Recently, 3 randomized controlled trials provided high-level evidence that patients with large ischemic stroke achieved better functional outcomes after endovascular therapy than with medical care alone. We aimed to investigate whether the clinical benefit of endovascular therapy is associated with the number of recanalization attempts in extensive baseline infarction. This retrospective multicenter study enrolled patients from the German Stroke Registry who underwent endovascular therapy for anterior circulation large vessel occlusion between 2015 and 2021. Large ischemic stroke was defined as an Alberta Stroke Program Early CT Score of 3 to 5. The study cohort was divided into patients with unsuccessful reperfusion (Thrombolysis in Cerebral Infarction score, 0-2a) and successful reperfusion (Thrombolysis in Cerebral Infarction score, 2b/3) at attempts 1, 2, 3, or ≥4. The primary outcome was favorable functional outcome defined as modified Rankin Scale score of 0 to 3 at 90 days. Safety outcomes were symptomatic intracranial hemorrhage after 24 hours and death within 90 days. Multivariable logistic regression was used to identify independent determinants of primary and secondary outcomes. A total of 348 patients met the inclusion criteria. Successful reperfusion was observed in 83.3% and favorable functional outcomes in 36.2%. Successful reperfusion at attempts 1 (adjusted odds ratio, 5.97 [95% CI, 1.71-24.43]; P=0.008) and 2 (adjusted odds ratio, 6.32 [95% CI, 1.73-26.92]; P=0.008) increased the odds of favorable functional outcome, whereas success at attempts 3 or ≥4 did not. Patients with >2 attempts showed higher rates of symptomatic intracranial hemorrhage (12.8% versus 6.5%; P=0.046). Successful reperfusion at any attempt lowered the odds of death compared with unsuccessful reperfusion. In patients with large vessel occlusion and Alberta Stroke Program Early CT Score of 3 to 5, the clinical benefit of endovascular therapy was linked to the number of recanalization attempts required for successful reperfusion. Our findings encourage to perform at least 2 recanalization attempts to seek for successful reperfusion in large ischemic strokes, while >2 attempts should follow a careful risk-benefit assessment in these highly affected patients. URL: https://www. gov; Unique identifier: NCT03356392.